| 1. | | Suspended | 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma
Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer |
| 2. | | Recruiting | Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Cancer |
| 3. | | Recruiting | Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Conditions: stage III prostate cancer; stage II prostate cancer |
| 4. | | Recruiting | Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 5. | | No longer recruiting | Bortezomib in Treating Patients With Mantle Cell Lymphoma
Conditions: stage I mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; ... |
| 6. | | Recruiting | Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia |
| 7. | | No longer recruiting | Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy
Condition: recurrent ovarian epithelial cancer |
| 8. | | Recruiting | CCI-779 in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer
Condition: Endometrial Cancer |
| 9. | | Recruiting | Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Conditions: Quality of Life; stage IV colon cancer; recurrent colon cancer; recurrent rectal cancer; Stage IV rectal cancer |
| 10. | | Recruiting | Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ... |
| 11. | | Recruiting | Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 12. | | No longer recruiting | Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Conditions: childhood thorax/respiratory cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; Quality of Life |
| 13. | | No longer recruiting | Chemotherapy in Treating Women With Resected Breast Cancer Following Tamoxifen Therapy
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
| 14. | | No longer recruiting | Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed
Conditions: stage III rectal cancer; adenocarcinoma of the rectum; stage II rectal cancer |
| 15. | | Completed | Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
Conditions: Squamous Cell Lung Cancer; Adenocarcinoma of the Lung; Bronchoalveolar Cell Lung Cancer; stage IIIA non-small cell lung cancer; ... |
| 16. | | No longer recruiting | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer (Pancoast Tumors)
Conditions: stage IIIA non-small cell lung cancer; Adenosquamous Cell Lung Cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; ... |
| 17. | | Recruiting | Cisplatin or Carboplatin Combined With Gemcitabine in Treating Patients With Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor
Conditions: high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer |
| 18. | | No longer recruiting | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
Conditions: stage IV bladder cancer; transitional cell carcinoma of the bladder; urethral cancer associated with invasive bladder cancer; ... |
| 19. | | No longer recruiting | Combination Chemotherapy in Treating Pain in Patients With Hormone Refractory Metastatic Prostate Cancer
Conditions: Pain; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life |
| 20. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Conditions: recurrent colon cancer; adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; ... |
| 21. | | Recruiting | Combination Chemotherapy in Treating Patients With Bladder Cancer
Conditions: stage I bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder |
| 22. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma That Has Not Responded to Previous Treatment
Conditions: recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; ... |
| 23. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
| 24. | | Completed | Combination Chemotherapy in Treating Patients With Stage III Colon Cancer
Conditions: stage III colon cancer; adenocarcinoma of the colon |
| 25. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy With or Without Gefitinib in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Conditions: Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
| 26. | | Recruiting | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer |
| 27. | | No longer recruiting | Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: refractory plasma cell neoplasm |
| 28. | | Recruiting | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Condition: adult Hodgkin's lymphoma |
| 29. | | Recruiting | Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: stage I adult diffuse large cell lymphoma; contiguous stage II adult diffuse large cell lymphoma; ... |
| 30. | | Recruiting | Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma |
| 31. | | Recruiting | Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; ... |
| 32. | | Recruiting | Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
| 33. | | Recruiting | Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
Conditions: stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder |
| 34. | | No longer recruiting | Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Conditions: Anorexia; Cachexia |
| 35. | | Recruiting | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
Conditions: adult lymphocyte depletion Hodgkin's lymphoma; adult mixed cellularity Hodgkin's lymphoma; adult nodular sclerosis Hodgkin's lymphoma; ... |
| 36. | | No longer recruiting | Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
Condition: gastrointestinal stromal tumor |
| 37. | | Recruiting | Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: anaplastic large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent adult diffuse large cell lymphoma; angioimmunoblastic T-cell lymphoma |
| 38. | | No longer recruiting | Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; Neutropenia |
| 39. | | Recruiting | Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Conditions: stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer |
| 40. | | No longer recruiting | Erlotinib and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer |
| 41. | | No longer recruiting | Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer
Conditions: stage IV endometrial cancer; recurrent endometrial cancer; endometrial adenocarcinoma; endometrial adenosquamous cell carcinoma |
| 42. | | No longer recruiting | Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 43. | | Recruiting | Exemestane Compared With Anastrozole, With or Without Celecoxib, in Treating Postmenopausal Women After Surgery for Primary Breast Cancer
Conditions: stage IIIA breast cancer; stage I breast cancer; stage II breast cancer |
| 44. | | Recruiting | Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
Condition: Breast Cancer |
| 45. | | Recruiting | Exemestane With or Without Celecoxib in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Condition: Breast Cancer |
| 46. | | No longer recruiting | Flavopiridol in Treating Patients With Metastatic Malignant Melanoma
Condition: Stage IV Melanoma |
| 47. | | No longer recruiting | Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma
Conditions: stage I mantle cell lymphoma; stage III mantle cell lymphoma; stage IV mantle cell lymphoma; recurrent mantle cell lymphoma; ... |
| 48. | | No longer recruiting | Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Conditions: stage IVB adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage III adult soft tissue sarcoma |
| 49. | | No longer recruiting | Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ... |
| 50. | | Recruiting | Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed
Condition: Non-small cell lung cancer |
